Primary workflow
Query the startup database
Search 5,616 companies by company, geography, evidence confidence, grants, private financing, trials, patents, publications, and FDA activity.
Find evidence-backed private biopharma startups.
Query resolved company records across public funding, private-financing filings, clinical trials, patents, publications, and recent FDA activity.
Database-first sourcing
Start with the company graph, then move into deeper diligence.
The startup database is the primary discovery surface. Translational IP search and live market monitoring remain available when a company or theme deserves a wider view.
Secondary workflow
Search IPs
Explore university and translational IP opportunities by category, institution, and theme before moving into investor-oriented analysis.
Database + analysis
A grounded workflow for sourcing and evaluating private biopharma opportunities.
A resolved startup graph anchors discovery. Source-linked market monitoring and AI-assisted analysis extend that evidence when deeper context is useful.
Resolved company records
Search one company index built from funding, research, clinical, patent, and regulatory data.
Evidence you can inspect
Results expose confidence tiers, matched records, source families, and separate funding totals.
Search-to-analysis handoff
Move from a database result into focused startup analysis without rerunning discovery on the web.
How It Works
Search the graph, inspect the evidence, then go deeper.
A tighter investor workflow for screening private biopharma opportunities from first signal through first-pass diligence.
Startup discovery
-
1
Query the startup database
Search by company, technology, geography, or evidence signal.
-
2
Inspect the matched evidence
Compare confidence, grants, Form D activity, trials, patents, publications, and FDA records.
-
3
Analyze a priority company
Carry the selected database result into the investor-oriented analysis workflow.
What investors get
-
1
Deterministic discovery
The same database filters return the same evidence-backed company set.
-
2
Better early-stage pattern recognition
Research, clinical, patent, funding, and regulatory signals appear in one company view.
-
3
Faster sourcing loops
Move from a broad theme to a shortlist without waiting for live web retrieval.
About
Built for a private biopharma market where context compounds.
Early-stage biopharma sourcing depends on seeing fragmented signals together: grants, spinouts, IP, patents, trial movement, and early fundraising. EternaJuVita turns those fragments into a more coherent investor workflow.
Private access
Your live view into private biopharma market formation.
Query the startup database to build a shortlist, then use live market data and IP search when you need broader context.
Customer service
Ask a question. Get a useful next step.
Our AI customer service assistant can help with investor access, data partnerships, sourcing workflows, and platform questions.
Human follow-up
Need a person? Choose Talk to a human and the assistant will send the conversation to our customer service team. Add your email so we can reply.